Synthetic polysaccharide antigens for immunological intervention in disease

Details for Australian Patent Application No. 2004280329 (hide)

Owner Eli Lilly and Company

Inventors Taylor, Kathleen Ann; Cohen, Charles Ellis; Cleveland, John Astor Jr.; Blackburn, Neil Thomas; Kraft, Angelika Regina; Blaszczak, Larry Chris

Agent Spruson & Ferguson

Pub. Number AU-B-2004280329

PCT Pub. Number WO2005/035588

Priority 60/503,784 17.09.03 US

Filing date 15 September 2004

Wipo publication date 21 April 2005

Acceptance publication date 24 March 2011

International Classifications

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/035588 Priority application(s): WO2005/035588

24 March 2011 Application Accepted

  Published as AU-B-2004280329

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280333-Humanization of antibodies

2004280327-Catalyst composition for ethylene polymerization